Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704901 | SCV000237236 | likely benign | not provided | 2021-05-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000643158 | SCV000764845 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426895 | SCV002730407 | uncertain significance | Cardiovascular phenotype | 2019-10-23 | criteria provided, single submitter | clinical testing | The p.R7163H variant (also known as c.21488G>A), located in coding exon 87 of the TTN gene, results from a G to A substitution at nucleotide position 21488. The arginine at codon 7163 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004537547 | SCV004120213 | uncertain significance | TTN-related disorder | 2022-09-26 | criteria provided, single submitter | clinical testing | The TTN c.48683G>A variant is predicted to result in the amino acid substitution p.Arg16228His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.034% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179479651-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Mayo Clinic Laboratories, |
RCV001704901 | SCV005413094 | uncertain significance | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing |